“For three years – that’s how long this wonder drug has been in shortage – they’ve been compounding copies of semaglutide injection for patients at a time when Novo Nordisk could not ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk ... known as semaglutide, has given rise to concerns about unregulated, compounded and counterfeit medicines. Its weight-loss drug Wegovy also ...

Hims & Hers started prescribing compounded semaglutide, the active ingredient in Novo Nordisk's diabetes drug Ozempic and Wegovy, in May of 2024. The company has largely had to stop offering the ...

Hims & Hers started prescribing compounded semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy ... a specific ingredient in a branded drug. But drugmakers and some health ...